[Remote] MRD Clinical Account Executive, New England at Tempus

Massachusetts, United States

Tempus Logo
Not SpecifiedCompensation
Senior (5 to 8 years), Expert & Leadership (9+ years)Experience Level
Full TimeJob Type
UnknownVisa
Healthcare, Biotechnology, Medical Devices, PharmaceuticalsIndustries

Skills

Key technologies and capabilities for this role

Precision MedicineHealthcare SalesBusiness DevelopmentClient Relationship ManagementStrategic PlanningTerritory ManagementMarket AnalysisOncologyMinimal Residual Disease (MRD) TestingLaboratory Services Agreements (LSAs)

Questions & Answers

Common questions about this position

What qualifications are required for the MRD Clinical Account Executive role?

Candidates need a B.S. in life science, biology, business, or marketing, with an MBA preferred, plus 3+ years of direct account management experience in a molecular diagnostic setting, focusing on MRD testing.

What key skills are needed for this position?

The role requires proven ability in consultative selling of molecular diagnostic solutions, in-depth knowledge of oncology diagnostics reimbursement, strong communication and project management skills, proficiency in Microsoft Office and Salesforce, and advanced presentation skills.

What is the location or territory for this job?

The role covers the New England territory, focusing on major U.S. cancer centers, health systems, and community practices.

What does Tempus expect in terms of company culture representation?

Tempus expects the representative to embody the company culture with integrity, respect, and trust to both external and internal stakeholders.

What makes a strong candidate for this MRD Clinical Account Executive position?

A strong candidate has 3+ years of account management in molecular diagnostics with MRD focus, experience engaging executive stakeholders, deep knowledge of oncology reimbursement, and consultative selling skills.

Tempus

AI-driven healthcare data analysis platform

About Tempus

Tempus focuses on enhancing patient outcomes through the use of data and artificial intelligence in healthcare. The company offers a platform that analyzes medical data to provide insights for physicians, helping them make better treatment decisions. This platform also aids pharmaceutical and biotech companies in drug development by identifying new targets and assessing treatment effectiveness. For patients, Tempus identifies personalized therapy options, particularly in cancer care, where their research has shown increased opportunities for tailored treatments. They have developed a pan-cancer organoid platform and a liquid biopsy assay for profiling circulating tumor DNA. Tempus generates revenue by charging healthcare providers and companies for access to their platform and insights, setting them apart from competitors by their focus on personalized medicine and extensive cancer research.

Chicago, IllinoisHeadquarters
2015Year Founded
$894.9MTotal Funding
IPOCompany Stage
AI & Machine Learning, Biotechnology, HealthcareIndustries
1,001-5,000Employees

Benefits

Relocation Assistance
Company Equity
Performance Bonus

Risks

Competition from partners like Genialis may lead to conflicts of interest.
Ambry Genetics acquisition could pose financial risks if synergies aren't realized.
Technical challenges may arise in integration with Flatiron's OncoEMR platform.

Differentiation

Tempus uses AI to analyze clinical and molecular data for precision medicine.
Their platform aids in personalized treatment decisions for cancer patients.
Tempus collaborates with biotech firms to enhance drug development using real-world data.

Upsides

Increased AI adoption in healthcare boosts Tempus' partnerships and collaborations.
Acquisition of Ambry Genetics expands Tempus' genetic testing capabilities.
Integration with Flatiron's OncoEMR enhances precision in cancer treatment plans.

Land your dream remote job 3x faster with AI